DP recptor signaling increased LPS-induced TNF-.ALPHA. production by macrophages.
スポンサーリンク
概要
- 論文の詳細を見る
Prostaglandin D<SUB>2</SUB> (PGD<SUB>2</SUB>) acts via the adenyl cyclase-coupled receptor for PGD<SUB>2</SUB> (DP receptor) . Previously, we presented evidence that BW245C, a DP receptor agonist, inhibited chemotaxis, phagocytosis, superoxide anion production and nitrite production, and potentiated TNF-α production by macrophages. To gain information on the mechanism through which agonist of DP receptor potentiated LPS-stimulated TNF-αproduction by macrophages, in this study, we sought to identify downstream effectors of DP receptor-potentiated TNF-αproduction. Both SB203580, a p38 mitogen-activated protein kinase (MAPK) inhibitor, and PD98059, an extracellular signal-related kinase (ERK) 1/2 inhibitor, prevented LPS-induced TNF-αproduction and BW245C-increased TNFαproduction in the presence of LPS, respectively. In contrast, LY294002, a phosphoinositide 3-kinase (PI3K) inhibitor, D609, a phospholipase C (PLC) inhibitor, and suramin, a PLD inhibitor, all did not affect LPS-induced TNF-αproduction, whereas they markedly inhibited BW245C-increased TNFαproduction in the presence of LPS. These results suggest that LPS evidently induced the production of TNF-αthrough p38 MAPK and ERK 1/2 signaling pathways, and that BW245C further increased LPS-induced TNF-αproduction through PI3K, PLC, and PLD.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果